The Role of Follistatin Domains in Follistatin Biological Action

Molecular Endocrinology

Volumn 18, Issue 1, 2004, Pages 228-240

  Keutmann, Henry T ^a   Schneyer, Alan L ^a   Sidis, Yisrael ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVIN; ALANINE; ASPARTIC ACID; EPITOPE; FOLLISTATIN; FOLLITROPIN; HEPARIN; MUTANT PROTEIN;

AMINO TERMINAL SEQUENCE; ANIMAL CELL; ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL CULTURE; CHO CELL; CONFORMATION; CONTROLLED STUDY; EMBRYO; EVALUATION; FEMALE; GENE DELETION; GENETIC TRANSCRIPTION; HORMONE RELEASE; HUMAN; HUMAN CELL; HYDROPHOBICITY; HYPOPHYSIS CELL; MAMMAL CELL; MOLECULE; NONHUMAN; POINT MUTATION; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION;

ACTIVINS; AMINO ACID SEQUENCE; BINDING SITES; CELL DIVISION; FOLLISTATIN; HUMANS; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; MUTAGENESIS, SITE-DIRECTED; POINT MUTATION; PROTEIN CONFORMATION; RECOMBINANT PROTEINS; TRANSFORMING GROWTH FACTOR BETA;

ANIMALIA; CRICETINAE; CRICETULUS GRISEUS; MAMMALIA;

EID: 0346025350     PISSN: 08888809     EISSN: None     Source Type: Journal    
DOI: 10.1210/me.2003-0112     Document Type: Article

References (60)

1. Welt C, Sidis Y, Keutmann HT, Schneyer AL 2002 Activins, inhibins and follistatins: from endocrinology to signalling - a paradigm for the new millennium. Exp Biol Med 227:724-752
2. Shimasaki S, Koga M, Esch F, Cooksey K, Mercado M, Koba A, Ueno N, Ying S-Y, Ling N, Guilleman R 1988 Primary structure of the human follistatin precursor and its genomic organization. Proc Natl Acad Sci USA 85: 4218-4222
3. Nakamura T, Takio K, Eto Y, Shibai H, Titani K, Sugino H 1990 Activin-binding protein from rat ovary is follistatin. Science 247:836-838
4. Schneyer AL, Rzucidlo DA, Sluss PM, Crowley WF 1994 Characterization of unique binding kinetics of follistatin and activin or inhibin in serum. Endocrinology 135: 667-674
5. Meriggiola M, Dahl KD, Mather JP, Bremner WJ 1994 Follistatin decreases activin-stimulated FSH secretion with no effect on GnRH-stimulated FSH secretion in prepubertal male monkeys. Endocrinology 134:1967-1970
6. deWinter JP, ten Dijke P, de Vries CJM, van Achterberg TAE, Sugino H, de Waele P, Huylebroeck D, Verschueren K, van den Eijnden-van Raaij AJM 1996 Follistatins neutralize activin bioactivity by inhibition of activin binding to its type II receptors. Mol Cell Endocrinol 116:105-114
7. Michel U, Farnworth P, Findlay JK 1993 Follistatins: more than follicle-stimulating hormone suppressing proteins. Mol Cell Endocrinol 91:1-11
8. DePaolo LV 1997 Inhibins, activins and follistatins: the saga continues. Proc Soc Exp Biol Med 214:328-339
9. Massague J, Chen YG 2000 Controlling TGF-β signaling. Genes Dev 14:627-644
10. Bernard DJ, Chapman SC, Woodruff TK 2001 An emerging role for co-receptors in inhibin signal transduction. Mol Cell Endocrinol 180:55-62
11. Balemans W, Van Hul W 2002 Extracellular regulation of BMP signaling in vertebrates: a cocktail of modulators. Dev Biol 250:231-250
12. Shi Y, Massague J 2003 Mechanisms of TGF-β signaling from cell membrane to the nucleus. Cell 113:685-700
13. Groppe J, Greenwald J, Wiater E, Rodriquez-Leon J, Economides AN, Kwiatkowski W, Affolter M, Vale WW, Belmonte JC, Choe S 2002 Structural basis of BMP signalling inhibition by the cystine knot protein noggin. Nature 420:636-642
14. Sidis Y, Schneyer AL, Sluss PM, Johnson LN, Keutmann HT 2001 Follistatin: essential role for the N-terminal domain in activin binding and neutralization. J Biol Chem 276:17718-17726
15. Gray PC, Greenwald J, Blound AL, Kunitake KS, Donaldson CJ, Choe S, Vale W 2000 Identification of a binding site on the Type II activin receptor for activin and inhibin. J Biol Chem 275:3206-3212
16. Greenwald J, Groppe J, Gray P, Wiater E, Kwiatkowski W, Vale W, Choe S 2003 The BMP7/ActRII extracellular domain complex provides new insights into the cooperative nature of receptor assembly. Mol Cell 11:605-617
17. Thompson TB, Woodruff TK, Jardetzky TS 2003 Structures of an ActRIIB:activin A complex reveal a novel binding mode for TGFβ ligand:receptor interactions. EMBO J 22:1555-1666
18. Patthy L, Nikolics K 1993 Functions of agrin and agrin-related proteins. Trends Neurosci 16:76-81
19. 2+-binding EF-hand. J Cell Biochem 57:341-350
20. Burgess RW, Skarnes WC, Sanes JR 2000 Agrin isoforms with distinct amino termini: differential expression, localization, and function. J Cell Biol 151:41-52
21. Brekken RA, Sage EH 2001 SPARC, a matricellular protein: at the crossroads of cell-matrix communication. Matrix Biol 19:815-827
22. Hohenester E, Maurer P, Timpl R 1997 Crystal structure of a pair of follistatin-like and EF-hand calcium-binding domains in BM-40. EMBO J 16:3778-3786
23. Innis CA, Hyvonen M 2003 Crystal structures of the heparan sulphate-binding domain of follistatin: insights into ligand binding. J Biol Chem 278:39969-39977
24. Van Q, Sage EH 1999 SPARC, a matricellular glycoprotein with important biological functions. J Histochem Cytochem 47:1495-1505
25. Uchida T, Wada K, Akamatsu T, Yonezawa M, Noguchi H, Mizoguchi A, Kasuga M, Sakamoto C 1999 A novel epidermal growth factor-like molecule containing two follistatin modules stimulates tyrosine phosphorylation of erbB-4 in MKN28 gastric cancer cells. Biochem Biophys Res Commun 266:593-602
26. Schneyer AL, Hall HA, Lambert-Messerlian G, Wang QF, Sluss P, Crowley WF 1996 Follistatin-activin complexes in human serum and follicular fluid differ immunologically and biochemically. Endocrinology 137:240-247
27. McConnell DS, Wang QF, Sluss PM, Bolf N, Khoury RH, Schneyer AL, Midgley AR, Reame NE, Crowley WF, Padmanabhan V 1998 A two-site chemiluminescent assay for activin-free follistatin reveals that most follistatin circulating in men and normal cycling women is in an activin-bound state. J Clin Endocrinol Metab 83:851-858
28. Sidis Y, Schneyer AL, Sluss PM, Johnson LN, Keutmann HT, Role of follistatin domain structure in activin binding and bioneutralization. Program of the 83rd Annual Meeting of The Endocrine Society, Denver, CO, 2001, p 361 (Abstract P2-318)
29. Gardella TJ, Rubin D, Abou-Samra A-B, Keutmann HT, Potts JTJ, Kronenberg HM, Nussbaum SR 1990 Expression of human parathyroid hormone-(1-84) in Escherichia coli as a factor X-cleavable fusion protein. J Biol Chem 265:15854-15859
30. Alliel PM, Perin J-P, Jolles P, Bonnet FJ 1993 Testican, a multidomain testicular proteoglycan resembling modulators of cell social behaviour. Eur J Biochem 214:347-350
31. Eib DW, Martens GJM 1996 A novel transmembrane protein with epidermal growth factor and follistatin domains expressed in the hypothalamo-hypophysial axis of Xenopus laevis. J Neurochem 67:1047-1055
32. Trexler M, Banyai L, Patthy L 2001 A human protein containing multiple types of protease-inhibitory modules. Proc Natl Acad Sci USA 98:3705-3709
33. Inouye S, Ling N, Shimasaki S 1992 Localization of the heparin-binding site of follistatin. Mol Cell Endocrinol 90:1-6
34. Wang QF, Keutmann HT, Schneyer AL, Sluss PM 2000 Analysis of human follistatin structure: identification of two discontinuous N-terminal sequences coding for activin A binding and structural consequences of activin binding to native proteins. Endocrinology 141: 3183-3193
35. Hayette S, Gadoux M, Martel S, Bertrand S, Tigaud I, Magaud J-P, Rimokh R 1998 FLRG (follistatin-related gene), a new target of chromosomal rearrangement in malignant blood disorders. Oncogene 16:2949-2954
36. Tsuchida K, Arai KY, Kuramoto Y, Yamakawa N, Hasegawa Y, Sugino H 2000 Identification and characterization of a novel follistatin-like protein as a binding protein for the TGF-β family. J Biol Chem 275:40788-40796
37. Schneyer AL, Tortoriello DV, Sidis Y, Keutmann HT, Matsuzaki T, Holmes WE 2001 Follistatin-related protein (FSRP): a new member of the follistatin gene family. Mol Cell Endocrinol 180:33-38
38. Sidis Y, Tortoriello DV, Holmes WE, Pan Y, Keutmann HT, Schneyer AL 2002 Follistatin-related protein and follistatin differentially neutralize endogenous vs. exogenous activin. Endocrinology 143:1613-1624
39. Tortoriello D, Pan Y, Holmes W, Sidis Y, Keutmann H, Schneyer A, Follistatin related protein (FSRP, FS-3, FLRG) and follistatin: are they functional homologues? In: International Workshop on Inhibins, Activins and Follistatins, Melbourne, Australia, 2000, p 127
40. Chang Y, Nilsen SL, Castellino FJ 1999 Functional and structural consequences of aromatic residue substitutions within the kringle-2 domain of tissue-type plasminogen activator. J Peptide Res 53:656-664
41. Sharma B, Kaushik N, Singh K, Kumar S, Pandey VN 2002 Substitution of conserved hydrophobic residues in motifs B and C of HIV-1 RT alters the geometry of its catalytic pocket. Biochemistry 41:15685-15697
42. Raines EW, Lane TF, Iruela-Arispe L, Ross R, Sage EH 1992 The extracellular glycoprotein SPARC interacts with platelet-derived growth factor (PDGF)-AB and -BB and inhibits the binding of PDGF to its receptors. Proc Natl Acad Sci USA 89:1281-1285
43. Kupprion C, Motamed K, Sage EH 1998 SPARC (BM-40, osteonectin) inhibits the mitogenic effect of vascular endothelial growth factor on microvascular endothelial cells. J Biol Chem 273:29635-29640
44. Busch E, Hohenester E, Timpl R, Paulsson M, Maurer P 2000 Calcium affinity, cooperativity, and domain interactions of extracellular EF-hands present in BM-40. J Biol Chem 275:25508-25515
45. Vannahme C, Smyth N, Miosge N, Gosling S, Frie C, Paulsson M, Maurer P, Hartmann U 2002 Characterization of SMOC-1, a novel modular calcium-binding protein in basement membranes. J Biol Chem 277:37977-37986
46. Denzer AJ, Schulthess T, Fauser C, Schumacher B, Kammerer RA, Engel J, Ruegg MA 1998 Electron microscopic structure of agrin and mapping of its binding site in laminin-1. EMBO J 17:335-343
47. Wiles AP, Shaw G, Bright J, Perczel A, Campbell JD, Barlow PN 1997 NMR studies of a viral protein that mimics the regulators of complement activation. J Mol Biol 272:253-265
48. Casanovas JM, Larvie M, Stehle T 1999 Crystal structure of two CD46 domains reveals an extended measles virus-binding surface. EMBO J 18:2911-2922
49. Schneyer AL, Wang QF, Weiss J, Boepple P, Hall J, Khoury R, Taylor A, Pralong F, Sluss P, Crowley WFJ 1997 Follistatin physiology and potential mechanisms of action in the human. In: Aono T, Sugino H, Vale W, eds. Inhibin, activin and follistatin: regulatory functions in system and cell biology. Kobe, Japan: Serono Symposia USA; pp 28-38
50. Delbaere A, Sidis Y, Schneyer AL 1999 Differential response to exogenous and endogenous activin in a human ovarian teratocarcinoma-derived cell line (PA-1): regulation by cell surface follistatin. Endocrinology 140: 2463-2470
51. Yamashita H, ten Dijke P, Huylebroeck D, Kuber-Sampath T, Andries M, Smith JC, Heldin C-H, Miyazono K 1995 Osteogenic protein-1 binds to activin type II receptors and induces certain activin-like effects. J Cell Biol 130:217-226
52. Tortoriello DV, Sidis Y, Holtzman DA, Holmes WE, Schneyer AL 2001 Human follistatin-related protein: a structural homologue of follistatin with nuclear localization. Endocrinology 142:3426-3434
53. Huang H-J, Wu JC, Su P, Zhirnov O, Miller WL 2001 A novel role for bone morphogenetic proteins in the synthesis of follicle-stimulating hormone. Endocrinology 142:2275-2283
54. Wozney JM, Rosen V 1998 Bone morphogenic protein and bone morphogenic protein gene family in bone formation and repair. Clin Orthop 346:26-37
55. Amthor H, Christ B, Rashid-Doubell F, Kemp CF, Lang E, Patel K 2002 Follistatin regulates bone morphogenetic protein-7 (BMP-7) activity to stimulate embryonic muscle growth. Dev Biol 243:115-127
56. Tsen G, Halfter W, Kroger S, Cole GJ 1995 Agrin is a heparan sulfate proteoglycan. J Biol Chem 270: 3392-3399
57. Winzen U, Cole G, Halfter W 2003 Agrin is a chimeric proteoglycan with the attachment sites for heparan sulfate/chondroitin sulfate located in two multiple serine-glycine clusters. J Biol Chem 278:30106-30114
58. Young J, Biden KG, Simms LA, Huggard P, Karamatic R, Eyre HJ, Sutherland GR, Herath N, Barker M, Andersohn GJ, Fitzpatrick DR, Ramm GA, Jass JR, Leggett BA 2001 HPP1: a transmembrane protein-encoding gene commonly methylated in colorectal polyps and cancers. Proc Natl Acad Sci USA 98:265-270
59. Wang QF, Khoury RH, Smith PC, McConnell DS, Padmanahban V, Midgley AR, Schneyer AL, Crowley WF, Sluss PM 1996 A two-site monoclonal antibody immunoradiometric assay for human follistatin: secretion by a human ovarian teratocarcinoma-derived cell line (PA-1). J Clin Endocrinol Metab 81:1434-1441
60. Scott RS, Burger HG, Quigg H 1980 A simple and rapid in vitro bioassay for inhibin. Endocrinology 107:1536-1542